Ventricular Fibrillation/Ventricular Tachycardia Within 72 h of VA-ECMO: Incidence, Outcomes, Risk Factors, and Management
ESC Heart Failure · 2024
DOI: 10.1002/ehf2.14615 ↗Kurz gefasst
Fachartikel in der Zeitschrift ESC Heart Failure, 2024. Verfasst von Hao Zhou und 7 weiteren Autor:innen. Beteiligte Einrichtung: Emergency Department, Nanjing Medical University First Affiliated Hospital and Jiangsu Province Hospital, Guangzhou Street 300, Nanjing, Jiangsu Prov…. Hauptthemen laut MEDLINE: Extracorporeal Membrane Oxygenation, Tachycardia, Ventricular, Heart Arrest. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Jiangsu Province Financial Support Clinical Key Specialty Program, Clinical Capacity Enhancement Project of Jiangsu Province Hospital.
Abstract (Originalsprache)
Aims
Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) is an important technique for the treatment of refractory cardiogenic shock and cardiac arrest; however, the early management of ventricular fibrillation/ventricular tachycardia (VF/VT), within 72 h of VA-ECMO, and its effects on patient prognosis remain unclear. Methods and results We retrospectively analysed patients at the First Affiliated Hospital of Nanjing Medical University who underwent VA-ECMO between January 2017 and March 2022. The patients were divided into two groups, VF/VT and nVF/VT, based on whether or not VF/VT occurred within 72 h after the initiation of VA-ECMO. We utilized logistic regression analysis to evaluate the independent risk factors for VF/VT in patients undergoing VA-ECMO and to ascertain whether the onset of VF/VT affected 28 day survival rate, length of intensive care unit stay, and/or other clinical prognostic factors. Subgroup analysis was performed for the VF/VT group to determine whether defibrillation affected prognosis. In the present study, 126 patients were included, 65.87% of whom were males (83/126), with a mean age of 46.89 ± 16.23, a 28 day survival rate of 57.14% (72/126), an incidence rate of VF/VT within 72 h of VA-ECMO initiation of 27.78% (35/126), and 80% of whom (28/35) received extracorporeal cardiopulmonary resuscitation. The incidence of VF/VT resulting from cardiac arrest at an early stage was significantly higher than that of refractory cardiogenic shock (80% vs. 20%; P = 0.022). The restricted cubic spline model revealed a U-shaped relationship between VF/VT incidence and initial heart rate (iHR), and multivariate logistic regression analysis showed that an iHR > 120 b.p.m. [odds ratio (OR) 6.117; 95% confidence interval (CI) 1.672–22.376; P = 0.006] and hyperlactataemia (OR 1.125; 95% CI 1.016–1.246; P = 0.023) within 1 h of VA-ECMO initiation were independent risk factors for the occurrence of VF/VT. VF/VT was not found to be associated with the 28 day survival of patients undergoing VA-ECMO support, nor did it affect other secondary endpoints. Defibrillation did not alter the overall prognosis in patients with VF/VT during VA-ECMO.
Conclusions
An iHR > 120 b.p.m. and hyperlactataemia were independent risk factors for the occurrence of VF/VT within 72 h of VA-ECMO initiation. The occurrence of VF/VT does not affect, nor does defibrillation in these patients improve the overall patient prognosis.
Trial registration
ChiCTR1900026105.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Emergency Department, Nanjing Medical University First Affiliated Hospital and Jiangsu Province Hospital, Guangzhou Street 300, Nanjing, Jiangsu Province, China.
Förderung
- National Natural Science Foundation of China
- Jiangsu Province Financial Support Clinical Key Specialty Program
- Clinical Capacity Enhancement Project of Jiangsu Province Hospital
Zitieren
APA
Zhou, H., Zhu, Y., Zhang, Z., Mei, Y., Lv, J., Zhang, G., Li, W., & Chen, X. (2024). Ventricular Fibrillation/Ventricular Tachycardia Within 72 h of VA-ECMO: Incidence, Outcomes, Risk Factors, and Management. ESC Heart Failure. https://doi.org/10.1002/ehf2.14615
Vancouver
Zhou H, Zhu Y, Zhang Z, Mei Y, Lv J, Zhang G, et al. Ventricular Fibrillation/Ventricular Tachycardia Within 72 h of VA-ECMO: Incidence, Outcomes, Risk Factors, and Management. ESC Heart Failure. 2024. doi:10.1002/ehf2.14615
BibTeX
@article{Zhou2024,
author = {Zhou, Hao and Zhu, Yi and Zhang, Zhongman and Mei, Yong and Lv, Jinru and Zhang, Gang and Li, Wei and Chen, Xufeng},
title = {Ventricular Fibrillation/Ventricular Tachycardia Within 72 h of VA-ECMO: Incidence, Outcomes, Risk Factors, and Management},
journal = {ESC Heart Failure},
year = {2024},
doi = {10.1002/ehf2.14615}
}
EUVIMED